There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

From new coordination methods to more transparency over lobbying, here’s how Ursula von der Leyen reshaped the Commission in ...

A series of reports released today by the European Centre for Disease Prevention and Control (ECDC) show sexually transmitted ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...

CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESSWIRE / 10, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whol ...

Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's ...

Al Tarifi explained that brokerage firms have been notified about the decision, which includes six items that describe the mechanism and procedures for handling dormant accounts.

Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase III trial results which ...

Africa has taken a significant step forward in addressing climate change adaptation with the establishment of the Adaptation Benefit Mechanism (ABM). This pioneering initiative, spearheaded by the ...

For a recent Creative Review webinar, in partnership with Figma, we asked top creative agencies DixonBaxi and R/GA to provide their take on how agencies can continue to create world-class work in ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's results. Click for this VYGR update.

The members of European Parliament (MEPs) welcome also Armenia’s decision to suspend work in the Collective Security Treaty Organization (CSTO), and recall the need for the immediate release of 23 ...